Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-049322

Options or other derivatives

  • General Counsel and Secretary acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2019-09-10 Grant or award · Restricted Stock Units +10,000 10,000 D
Loading xslF345X03/doc4.xml…